# Post-bypass Prophylactic IVIG in Infants and Neonates

> **NCT02043379** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 50 (actual)

## Conditions studied

- Hypogammaglobulinemia
- Congenital Heart Disease

## Interventions

- **DRUG:** IVIG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02043379
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043379, "Post-bypass Prophylactic IVIG in Infants and Neonates". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02043379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*